APO RESEARCH · REPORT
Plasminogen
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
Product & engineering
Understand the product.
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
Selected research
Market Structure
Global Plasminogen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen). Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
Global Plasminogen key players include Kedrion, Prometic, Genentech (Roche), Boehringer Ingelheim, Kyowa Hakko Kirin, etc. North America is the largest market, with a share about 45%, followed by Europe, with a share about 20 percent. In terms of product, Eye Drops is the largest segment, with a share about 88%.
This report provides an overview of the global Plasminogen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Plasminogen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plasminogen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plasminogen market size, projected growth trends, production technologies, key applications, and end-use industries.
Plasminogen Segment by Company
Kedrion
Prometic
Genentech (Roche)
Boehringer Ingelheim
Kyowa Hakko Kirin
Omeros Corporation
Plasminogen Segment by Type
Intravenous Injection
Eye Drops
Plasminogen Segment by Application
Ligneous Conjunctivitis
Diabetic Foot
Wound Healing
Others
Plasminogen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasminogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasminogen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasminogen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Plasminogen market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasminogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plasminogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Plasminogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Intravenous Injection
- Eye Drops
Applications
- Ligneous Conjunctivitis
- Diabetic Foot
- Wound Healing
- Others
Companies covered
- Kedrion
- Prometic
- Genentech (Roche)
- Boehringer Ingelheim
- Kyowa Hakko Kirin
- Omeros Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plasminogen Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plasminogen Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Plasminogen Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Plasminogen Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Plasminogen Market Dynamics
- 2.1 Plasminogen Industry Trends
- 2.2 Plasminogen Industry Drivers
- 2.3 Plasminogen Industry Opportunities and Challenges
- 2.4 Plasminogen Industry Restraints
3 Plasminogen Market by Manufacturers
- 3.1 Global Plasminogen Revenue by Manufacturers (2021-2026)
- 3.2 Global Plasminogen Sales by Manufacturers (2021-2026)
- 3.3 Global Plasminogen Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Plasminogen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Plasminogen Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Plasminogen Manufacturers, Product Type & Application
- 3.7 Global Plasminogen Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Plasminogen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Plasminogen Players Market Share by Revenue in 2025
- 3.8.3 2025 Plasminogen Tier 1, Tier 2, and Tier 3
4 Plasminogen Market by Type
- 4.1 Plasminogen Type Introduction
- 4.1.1 Intravenous Injection
- 4.1.2 Eye Drops
- 4.2 Global Plasminogen Sales by Type
- 4.2.1 Global Plasminogen Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plasminogen Sales by Type (2021-2032)
- 4.2.3 Global Plasminogen Sales Market Share by Type (2021-2032)
- 4.3 Global Plasminogen Revenue by Type
- 4.3.1 Global Plasminogen Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Plasminogen Revenue by Type (2021-2032)
- 4.3.3 Global Plasminogen Revenue Market Share by Type (2021-2032)
5 Plasminogen Market by Application
- 5.1 Plasminogen Application Introduction
- 5.1.1 Ligneous Conjunctivitis
- 5.1.2 Diabetic Foot
- 5.1.3 Wound Healing
- 5.1.4 Others
- 5.2 Global Plasminogen Sales by Application
- 5.2.1 Global Plasminogen Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plasminogen Sales by Application (2021-2032)
- 5.2.3 Global Plasminogen Sales Market Share by Application (2021-2032)
- 5.3 Global Plasminogen Revenue by Application
- 5.3.1 Global Plasminogen Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Plasminogen Revenue by Application (2021-2032)
- 5.3.3 Global Plasminogen Revenue Market Share by Application (2021-2032)
6 Global Plasminogen Sales by Region
- 6.1 Global Plasminogen Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plasminogen Sales by Region (2021-2032)
- 6.2.1 Global Plasminogen Sales by Region (2021-2026)
- 6.2.2 Global Plasminogen Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plasminogen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Plasminogen Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Plasminogen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Plasminogen Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Plasminogen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Plasminogen Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Plasminogen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Plasminogen Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Plasminogen Revenue by Region
- 7.1 Global Plasminogen Revenue by Region
- 7.1.1 Global Plasminogen Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Plasminogen Revenue by Region (2021-2026)
- 7.1.3 Global Plasminogen Revenue by Region (2027-2032)
- 7.1.4 Global Plasminogen Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Plasminogen Revenue (2021-2032)
- 7.2.2 North America Plasminogen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Plasminogen Revenue (2021-2032)
- 7.3.2 Europe Plasminogen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Plasminogen Revenue (2021-2032)
- 7.4.2 Asia-Pacific Plasminogen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Plasminogen Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Plasminogen Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Kedrion
- 8.1.1 Kedrion Company Information
- 8.1.2 Kedrion Business Overview
- 8.1.3 Kedrion Plasminogen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Kedrion Plasminogen Product Portfolio
- 8.1.5 Kedrion Recent Developments
- 8.2 Prometic
- 8.2.1 Prometic Company Information
- 8.2.2 Prometic Business Overview
- 8.2.3 Prometic Plasminogen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Prometic Plasminogen Product Portfolio
- 8.2.5 Prometic Recent Developments
- 8.3 Genentech (Roche)
- 8.3.1 Genentech (Roche) Company Information
- 8.3.2 Genentech (Roche) Business Overview
- 8.3.3 Genentech (Roche) Plasminogen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Genentech (Roche) Plasminogen Product Portfolio
- 8.3.5 Genentech (Roche) Recent Developments
- 8.4 Boehringer Ingelheim
- 8.4.1 Boehringer Ingelheim Company Information
- 8.4.2 Boehringer Ingelheim Business Overview
- 8.4.3 Boehringer Ingelheim Plasminogen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Boehringer Ingelheim Plasminogen Product Portfolio
- 8.4.5 Boehringer Ingelheim Recent Developments
- 8.5 Kyowa Hakko Kirin
- 8.5.1 Kyowa Hakko Kirin Company Information
- 8.5.2 Kyowa Hakko Kirin Business Overview
- 8.5.3 Kyowa Hakko Kirin Plasminogen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Kyowa Hakko Kirin Plasminogen Product Portfolio
- 8.5.5 Kyowa Hakko Kirin Recent Developments
- 8.6 Omeros Corporation
- 8.6.1 Omeros Corporation Company Information
- 8.6.2 Omeros Corporation Business Overview
- 8.6.3 Omeros Corporation Plasminogen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Omeros Corporation Plasminogen Product Portfolio
- 8.6.5 Omeros Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Plasminogen Value Chain Analysis
- 9.1.1 Plasminogen Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Plasminogen Production Mode & Process
- 9.2 Plasminogen Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Plasminogen Distributors
- 9.2.3 Plasminogen Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst